Kenneth Lin

Kenneth Lin

Director/Board Member at ANEBULO PHARMACEUTICALS, INC.

Net worth: - $ as of 30/05/2026

53 year
Finance
Health Technology
Consumer Services

Profile

Kenneth S.
Lin
was the founder of Ab Initio Biotherapeutics, Inc. (2015) and served as President & Chief Executive Officer from 2015 to 2019.
Current jobs include Independent Director at Anebulo Pharmaceuticals, Inc. since 2021 and Advisor at Tarrant Capital IP LLC since 2008.
Former jobs include Director at Vibrynt, Inc., Director at Conventus Orthopaedics, Inc., VP-Corporate Development & Investor Relations at Ulthera, Inc. from 2012 to 2014, Research Associate at Goldman Sachs & Co. LLC from 2000 to 2002, Associate at J.P.
Morgan Partners LLC, Associate at Panorama Capital LLC, and Vice President at TPG, Inc. from 2008 to 2012.
Education includes an undergraduate degree from Stanford University (1994) and a doctorate from Case Western Reserve University (1999).

Known holdings in public companies

CompanyDateNumber of sharesValuationValuation date
25/09/2025 0 ( -.--% ) - $ 30/05/2026

Kenneth Lin active positions

CompaniesPositionStart
ANEBULO PHARMACEUTICALS, INC. Director/Board Member 31/01/2021
Corporate Officer/Principal 12/06/2012

Former positions of Kenneth Lin

CompaniesPositionEnd
Chief Executive Officer 30/06/2019
Investor Relations Contact 30/06/2014
TPG INC. Corporate Officer/Principal 31/05/2012
Corporate Officer/Principal 30/12/2007
Analyst-Equity 30/12/2002
See the detail of Kenneth Lin's experience

Training of Kenneth Lin

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

Connections

95

1st degree connections

12

1st degree companies

Male

Female

Members of the board

Executives

Linked companies

Private companies12

Health Technology

Health Technology

Health Services

Consumer Services

Finance

Finance

Consumer Services

Finance

Finance

Health Technology

Health Technology

Finance